Skip to main content
. 2024 Nov 27;160(3-4):267–278. doi: 10.25259/IJMR_1527_2024

Table II.

Vaccines introduced in WHO South-East Asia region

OPV BCG DPT Measles Hep B Penta MCV2 Rubella IPV Rota VV JEV COVID-19 PCV TCV HPV Hepatitis B BD IPV2 DTP booster
Bangladesh 1979 1979 1979 1982 2003 2009 2000 2012 2015 2021 2015 2023* 2017
Bhutan 1979 1979 1979 1980 1997 2009 2010 2008 2015 2021 2019 2011 2012 2022 2013
DPR Korea 1980 1980 1980 1980 2003 2012 2008 2019 2015 2004
India 1972 1948 1978 1985 2023 2011 2010 2017 2015 2016 2007 2021 2017 2016* 2007 2015 1995
Indonesia 1977 1977 1977 1977 1997 2013 2004 2017 2016 2022 2018 2021 2017 2016* 2008 2022 2013
Maldives 1988 1971 1985 1983 1993 2013 2007 2017 2015 2021 1993 2018
Myanmar 1987 1978 1978 1987 2003 2012 2008 2015 2015 2020 2017 2021 2016 2020 2016 2023
Nepal 1978 1978 1978 1979 2005 2009 2015 2013 2014 2020 2007 2021 2015 2022 2018
Sri Lanka 1962 1959 1961 1984 2003 2008 2003 1996 2015 1988 2021 2017 2016
Thailand 1982 1977 1977 1984 2008 2019 2000 1986 2015 2020 1990 2021 2021* 2017 1992 1995
Timor-Leste 1978 1978 1978 1978 2007 2012 2015 2016 2016 2019 - 2021 2023 2024 2016 2017
*

subnational introduction. OPV, oral polio vaccine; BCG, Bacillus Calmette-Guerin; DPT, diphtheria, pertussis and tetanus; MCV, measles containing vaccine; IPV, injectable polio virus; PCV, pneumococcal conjugate vaccine; TCV, typhoid conjugate vaccine; JEV, Japanese encephalitis vaccine; HPV, human papilloma vaccine; BD, birth dose.

Source: Ref 26 (reproduced with permission from WHO Regional office for SEAR)